A Scoping Review of International Barriers to Asthma Medication Adherence Mapped to the Theoretical Domains Framework
- PMID: 32861047
- PMCID: PMC8006066
- DOI: 10.1016/j.jaip.2020.08.021
A Scoping Review of International Barriers to Asthma Medication Adherence Mapped to the Theoretical Domains Framework
Abstract
Background: Internationally, adult asthma medication adherence rates are low. Studies characterizing variations in barriers by country are lacking.
Objective: To conduct a scoping review to characterize international variations in barriers to asthma medication adherence among adults.
Methods: MEDLINE, EMBASE, Web of Science (WOS), and CINAHL were searched from inception to February 2017. English-language studies employing qualitative methods (eg, focus groups, interviews) were selected to assess adult patient- and/or caregiver-reported barriers to asthma medication adherence. Two investigators independently identified, extracted data, and collected study characteristics, methodologic approach, and barriers. Barriers were mapped using the Theoretical Domains Framework and findings categorized according to participants' country of residence, countries' gross national income, and the presence of universal health care (World Health Organization definitions).
Results: Among 2942 unique abstracts, we reviewed 809 full texts. Among these, we identified 47 studies, conducted in 12 countries, meeting eligibility. Studies included a total of 2614 subjects, predominately female (67%), with the mean age of 19.1 to 70 years. Most commonly reported barriers were beliefs about consequences (eg, medications not needed for asthma control, N = 29, 61.7%) and knowledge (eg, not knowing when to take medication, N = 27, 57.4%); least common was goals (eg, asthma not a priority, N = 1, 2.1%). In 27 studies conducted in countries classified as high income (HIC) with universal health care (UHC), the most reported barrier was participants' beliefs about consequences (N = 17, 63.3%). However, environmental context and resources (N = 12, 66.7%) were more common in HIC without UHC.
Conclusion: International adherence barriers are diverse and may vary with a country's sociopolitical context. Future adherence interventions should account for trends.
Keywords: African American; Asthma; Behavior change; Behavioral research; Black; Compliance; Gross national income; Medication adherence; Qualitative research; Theoretical Domains Framework; Universal health care; World Health Organization.
Copyright © 2020 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest: The authors declare that they have no relevant conflicts of interest.
Figures
References
-
- Global Initiative for Asthma. The Global Asthma Report 2018. Auckland, New Zealand: Global Asthma Network; 2018. Available from: http://www.globalasthmareport.org/Global%20Asthma%20Report%202018.pdf. Accessed February 24, 2020.
-
- Bender BG, Rand C. Medication non-adherence and asthma treatment cost. Curr Opin Allergy Clin Immunol 2004;4:191–5. - PubMed
-
- Engelkes M, Janssens HM, de Jongste JC, Sturkenboom MC, Verhamme KM. Medication adherence and the risk of severe asthma exacerbations: a systematic review. Eur Respir J 2015;45:396–407. - PubMed
-
- Bateman E, Hurd S, Barnes P, Bousquet J, Drazen J, FitzGerald M, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31:143–78. - PubMed
-
- Bender BG, Bender SE. Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires. Immunol Allergy Clin North Am 2005;25:107–30. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
